Home Multimedia Podcasts HOW TO MAKE BIOINDUSTRY ALLIANCES WORK MORE EFFICIENTLY AND EFFECTIVELY HOW TO MAKE BIOINDUSTRY ALLIANCES WORK MORE EFFICIENTLY AND EFFECTIVELY March 19, 2009 – Interview with Salima Lin, Global Strategy and Market Development Leader, IBM’s Life Science Industry /wp-content/uploads/2018/09/gc255_3_19_2009.mp3 DrugsHealth care and economicsHealth care economicsHealth care facility, manpower, and servicesHealth care investmentPharmacology Also of Interest Alexandria Founder Talks Takeda, Massachusetts, NYC, and 30th Anniversary Lab Space Giant Alexandria Real Estate Navigates AI’s Impact on Biopharma Leveraging Data Science for Drug Development 89bio’s MASH Drug Begins Phase III, Aiming to Stand Out in Growing Field With $86M Oversubscribed Public Offering, Absci Eyes 2025 IND for Lead Candidate StockWatch: Challengers Take Aim at Lilly, Novo Nordisk Related Media BIO CEO Rachel King Outlines Industry's Challenges on "Close to the Edge" Carl Icahn States His Case for Change at Illumina on "Close to the Edge" Emerging Markets Collaborate to Succeed in Post-Pandemic World Global Single-Use Network Support Assurance of Supply Reporter's Notebook: Opening Day at the J.P. Morgan Healthcare Conference Resins Address Downstream Purification Concerns Related Content Alexandria Founder Talks Takeda, Massachusetts, NYC, and 30th Anniversary Lab Space Giant Alexandria Real Estate Navigates AI’s Impact on Biopharma Leveraging Data Science for Drug Development 89bio’s MASH Drug Begins Phase III, Aiming to Stand Out in Growing Field